Navigation Links
Cocaine Acts As Suppressant Not Stimulant In Genetically Altered Mice

Researchers at the Ohio State University have found that cutting off the reward pathway of cocaine on mice by genetically altering a vital target in the brain of the mice makes them shun cocaine//.

Howard Gu, the study’s lead author and an associate professor of pharmacology and psychiatry at Ohio State University said that the researchers were not suggesting that humans be treated in the same way, but had identified the key protein, which controls cocaine’s effects in the body.

'Cocaine blocks dopamine transporters, and this action ultimately is what makes a person feel high,' Gu said. 'We found that cocaine would not produce a high if it could not block the transporters.' The study appears in May 29 issue of the Proceedings of the National Academy of Sciences.

Dopamine is a chemical messenger in the brain, which is vital for the functioning of the nervous system. Cocaine blocks the dopamine transmitter as its principal effect, the researchers altered this gene that codes for the dopamine transporter in the mice.

'By doing so we created a dopamine transporter that resists cocaine but also retains its function of taking up dopamine and carrying it back to the neurons,' Gu said.

Now researchers spilt the mice into two groups, the normal ones and the ones with the altered genes and gave them cocaine injections. 'After the cocaine injections, the normal mice ran all over the place, sniffing and checking everything out in the box over and over again, until we took them out of the box,' Gu said. 'But cocaine seemed to calm the modified mice, as they sat in a corner for long periods of time.'

'Deleting the dopamine transporter itself caused tremendous changes in the mouse brain,' Gu said. 'It’s possible that, somehow, the animals’ brains rewired themselves and, as a result, the mice still felt the effects of cocaine.'


Page: 1

Related medicine news :

1. Medications to Prevent Relapse to Cocaine Use
2. Ritalin May Lower Cocaine Abuse
3. Lethal Heart Condition linked To Cocaine Use
4. Cocaine may cause aneurysms for the coronart artery
5. Regular Use Of Cocaine Can Impair Brain Functions
6. Brain of Cocaine Addicts Smaller In Size
7. Sensations Generated By Cocaine And Methamphetamine Abuse Are Not Same.
8. Cocaine Kates Lover Wants to Kick his Drug Habit
9. One Nigerian Cocaine Pedellar Nabbed
10. UN Sounds Alarm Over Rising Cocaine Consumption In Europe
11. Definite Connection Between Receptor Levels and Cocaine Abuse Reveals PET Imaging
Post Your Comments:

(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: